Predictive Survival Factors for Patients With Urothelial Carcinoma Who Progress After Platinum-Based Therapy and Are Started on Immunotherapy

PrecisCa

PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios

https://precisca.com/